ARK Invest Acquires $6.1 Million Stake in Recursion Pharmaceuticals (RXRX) While Divesting Twist Bioscience

ARK Invest Acquires $6.1 Million Stake in Recursion Pharmaceuticals (RXRX) While Divesting Twist Bioscience

Cathie Wood's ARK Invest sold $17.1M in Twist Bioscience and purchased Recursion Pharmaceuticals, Intellia Therapeutics, and Veracyte shares on Oct. 5.

Cathie Wood’s ARK Sells Twist Bioscience Shares, Buys Recursion and Intellia

TLDR Cathie Wood’s ARK Invest sold 90,713 shares of Twist Bioscience worth about $17.1 million on October 5, 2026. ARK bought 1,482,357 shares of Recursion Pharmaceuticals worth about $6.1 million. ARK purchased 96,308 shares of Intellia Therapeutics valued at about $1.18 million. ARK also bought...